**Core Concept**
The question is testing the student's knowledge of NK1 receptor antagonists, a class of drugs used to prevent vomiting, particularly in the context of chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV).

**Why the Correct Answer is Right**
The correct answer is a NK1 receptor antagonist that selectively blocks the action of substance P at its receptor site in the central nervous system, thereby preventing the vomiting reflex. This class of drugs is particularly effective in preventing acute CINV and PONV. The mechanism of action involves the inhibition of substance P, which is a key neurotransmitter involved in the vomiting pathway.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specifically refer to a NK1 receptor antagonist. While there are other classes of antiemetic drugs, such as serotonin 5-HT3 receptor antagonists, they have a different mechanism of action and are not the correct answer to this question.

**Option B:** This option is incorrect because it is a drug class that is used to treat nausea and vomiting, but it is not a NK1 receptor antagonist. Corticosteroids, such as dexamethasone, are used to prevent CINV and PONV, but they work through a different mechanism of action.

**Option C:** This option is incorrect because it is a type of antiemetic drug, but it is not a NK1 receptor antagonist. Metoclopramide is a dopamine antagonist that is used to treat nausea and vomiting, but it has a different mechanism of action and is not the correct answer to this question.

**Clinical Pearl / High-Yield Fact**
NK1 receptor antagonists, such as aprepitant, are particularly effective in preventing acute CINV and PONV, and are often used in combination with other antiemetic drugs to enhance their efficacy.

**Correct Answer:** D. Aprepitant